Nothing currently in dispute alters the fact that the industry groups agreed to a shift in the use of legal these terms which delivers a dramatic and probably irreversible expansion in the government's power to extract price reductions from companies with PBS-listed medicines. …
Why would it take these powers if it did not intend to use them?
September 28, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
New Zealand's pre-election Budget boosts health spending, but Pharmac misses out
May 29, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 29 May
May 28, 2026 - - Podcast -
AusBiotech unites conferences under the banner of the 'Biggest Week' in biotech
May 28, 2026 - - Australian Biotech -
Research highlighting gaps leaving some communities at greater risk as flu
May 28, 2026 - - Latest News -
A fraught process but also an opportunity to reintroduce ideas sidelined by the review
May 28, 2026 - - Latest News -
Single infusion of Lilly gene editing cuts cholesterol with the company planning long-term study
May 27, 2026 - - Latest News -
ARCS launches national partnership to boost public clinical research sites
May 27, 2026 - - Latest News